Author pages are created from data sourced from our academic publisher partnerships and public sources.
On death and dying.
Dr. J. Russell Little, Chief, Division of Infectious Disease, the Jewish Hospital of St. Louis and Associate Professor of Medicine and Microbiology, Washington University School of Medicine: Our… Expand
Thrombosis in the presence of vascular stasis.
- S. Wessler
- The American journal of medicine
- 1 November 1962
The conus artery; a third coronary artery.
Biologic assay of a thrombosis-inducing activity in human serum.
The systemic infusion of thrombin-free human serum induces massive thrombosis in rabbit vein segments containing stagnant blood far removed from the site of infusion. In contrast, carefully collect...
Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass.
The activated clotting time (ACT) with a Hemochron system for determining heparin requirements during cardiopulmonary bypass surgery, (CPB) accompanied by hemodilution and hypothermia was evaluated… Expand
Efficacy of low doses of heparin in prevention of deep-vein thrombosis after major surgery. A double-blind, randomised trial.
Interarterial Coronary Anastomoses in the Human Heart, with Particular Reference to Anemia and Relative Cardiac Anoxia
In an unselected series of 1050 human hearts the coronary arteries were uniformly injected at necropsy with a standardized radiopaque mass. Interarterial coronary anastomoses were clearly… Expand
Inhibition of human activated Factor X by antithrombin III and alpha 1-proteinase inhibitor in human plasma.
- S. Gitel, V. M. Medina, S. Wessler
- Chemistry, Medicine
- The Journal of biological chemistry
- 10 June 1984
The inhibition of activated human Factor X by human plasma protease inhibitors was investigated in both purified and plasma systems. In the former, antithrombin III, alpha 1-proteinase inhibitor, and… Expand
Bacterioidaceae endotoxin detection by Limulus assay.